Guo et al., have documented that emodin mediated inhibition of MDR1/P-glycoprotein and expression of MRPs alleviates gemcitabine resistance in pancreatic cancer (Guo et al., 2020). Here, ABCB1 is linked to familial pancreatic carcinoma.